Last October, Mitologics participated in the RespiriTB consortium 2024 online Annual Meeting.
We reviewed the last six months of most of the RespiriTB work packages and the outcome of the work done to date. It was a pleasure to see that the project has reached several important milestones in recent years in preparation for clinical trials, but also in the hit-to-lead optimization, a work package involving Mitologics.
Mitologics is very proud to be part of the RespiriTB consortium which actively works to develop effective, user-friendly treatments that can significantly impact patient care in the fight against tuberculosis. We deeply appreciate the consortium and we are looking forward to the next, and unfortunately the last, Annual Meeting, scheduled in Vienna, Austria, on 13 and 14 March.
Learn more here
